The ‘angiogenic switch’ in the progression from Barrett's metaplasia to esophageal adenocarcinoma
- 31 December 2003
- journal article
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 29 (10) , 890-894
- https://doi.org/10.1016/j.ejso.2003.07.002
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Malignant Degeneration of Barrett’s Esophagus: Clinical Point of ViewPublished by Springer Nature ,2000
- Malignant Progression in Barrett’s Esophagus: Pathology and Molecular BiologyPublished by Springer Nature ,2000
- Effects of Angiogenesis Inhibitors on Multistage Carcinogenesis in MiceScience, 1999
- Molecular Evolution of the Metaplasia-Dysplasia-Adenocarcinoma Sequence in the EsophagusThe American Journal of Pathology, 1999
- Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawalJournal of Clinical Investigation, 1999
- Transgenic mouse models of tumour angiogenesis: the angiogenic switch, its molecular controls, and prospects for preclinical therapeutic modelsEuropean Journal Of Cancer, 1996
- Quantification of angiogenesis in solid human tumours: an international consensus on the methodology and criteria of evaluationEuropean Journal Of Cancer, 1996
- Clinical implications of p53 gene mutation in the progression of Barrett's epithelium to invasive esophageal cancerThe American Journal of Surgery, 1994
- Relation of neovascularisation to metastasis of non-small-cell lung cancerThe Lancet, 1992
- Tumor Angiogenesis and Metastasis — Correlation in Invasive Breast CarcinomaNew England Journal of Medicine, 1991